Polygenic risk for schizophrenia predicting age-specific fluctuations in depressive symptoms: Findings from the Young Finns Study

BACKGROUND: A well-established connection exists between psychoses and depression, with one presentation being depressive symptoms before psychosis. However, the predictive power of preceding affective symptoms is reported to be low, raising the question whether depressive symptoms could reflect intermediary phenotypes associated with high polygenic risk for schizophrenia (PRSscz). We examined whether PRSscz is associated with depressive symptoms from adolescence to middle age in those who did not develop a non-affective psychosis. METHODS: We used the population-based Young Finns Study (n = 2291). Depressive symptoms were measured with the Beck Depression Inventory-II and its modified version (suitable for non-clinical symptoms) between ages 15 and 56. Covariates included age, sex, childhood family environment, and adulthood education and income. The Care Register for Health Care was used to exclude participants with non-affective psychoses until middle age. RESULTS: High PRSscz was associated with higher performance difficulties from adolescence to early adulthood and higher depressive cognitions when approaching middle age. These associations were sustained in the fully adjusted models. PRSscz did not show consistent associations with the total amount of depressive symptoms or somatic/affective symptoms. CONCLUSIONS: First, PRSscz appears to explain age-specific fluctuations in depressive symptoms. Second, PRSscz may not predict the full symptom profile of major depression (i.e., it was not associated with affective/somatic symptoms). Third, high PRSscz explains depressive symptoms during periods typical for prodromal syndromes, even among those who do not develop psychosis. Thus, depressive symptoms in adolescence may represent intermediary phenotypes or transdiagnostic susceptibilities related to high PRSscz.

Authors

Institutions

Publication Details

Journal
Schizophrenia Research
Published
2026-10-17
DOI
https://doi.org/10.1016/j.schres.2026.10.009
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polygenic risk for schizophrenia predicting age-specific fluctuations in depressive symptoms: Findings from the Young Finns Study

Aino I. L. Saarinen, Elina Sormunen, Liisa Keltikangas‐Järvinen, Mika A. P. Kähönen et al.
Schizophrenia Research
Schizophrenia research and treatment
article

Polygenic risk for schizophrenia predicting age-specific fluctuations in depressive symptoms: Findings from the Young Finns Study

Aino I. L. Saarinen, Elina Sormunen, Liisa Keltikangas‐Järvinen, Mika A. P. Kähönen, Olli Tuomas Raitakari, Jarmo A. Hietala, Leo‐Pekka Lyytikäinen, Terho J. Lehtimäki, Veikka Lavonius
article en

Abstract

BACKGROUND: A well-established connection exists between psychoses and depression, with one presentation being depressive symptoms before psychosis. However, the predictive power of preceding affective symptoms is reported to be low, raising the question whether depressive symptoms could reflect intermediary phenotypes associated with high polygenic risk for schizophrenia (PRSscz). We examined whether PRSscz is associated with depressive symptoms from adolescence to middle age in those who did not develop a non-affective psychosis. METHODS: We used the population-based Young Finns Study (n = 2291). Depressive symptoms were measured with the Beck Depression Inventory-II and its modified version (suitable for non-clinical symptoms) between ages 15 and 56. Covariates included age, sex, childhood family environment, and adulthood education and income. The Care Register for Health Care was used to exclude participants with non-affective psychoses until middle age. RESULTS: High PRSscz was associated with higher performance difficulties from adolescence to early adulthood and higher depressive cognitions when approaching middle age. These associations were sustained in the fully adjusted models. PRSscz did not show consistent associations with the total amount of depressive symptoms or somatic/affective symptoms. CONCLUSIONS: First, PRSscz appears to explain age-specific fluctuations in depressive symptoms. Second, PRSscz may not predict the full symptom profile of major depression (i.e., it was not associated with affective/somatic symptoms). Third, high PRSscz explains depressive symptoms during periods typical for prodromal syndromes, even among those who do not develop psychosis. Thus, depressive symptoms in adolescence may represent intermediary phenotypes or transdiagnostic susceptibilities related to high PRSscz.

Schizophrenia ResearchVol. 298
University of Helsinki (FI), Tampere University of Applied Sciences (FI), University of Turku (FI), Tampere University (FI), Turku University Hospital (FI), Tampere University Hospital (FI), Tampere University (FI), Fimlab (Finland) (FI), University of Tampere (FI)
Good health and well-being
Openalex Percentile: Top 12%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.